Major Neurocognitive Disorder
11
4
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (11)
Cross-cultural Adaptation of the Safety Assessment Scale for Elderly People With a Major Neurocognitive Disorder Living at Home.
Italian Adaptation and Validation of Functional and Behavioural Scales for Subjective Cognitive Decline, Mild Cognitive Impairment and Mild Dementia.
E-health and People Living With Major Neurocognitive Disorder - CARE© and ESOGER© Applications
Exergaming Revolution in Dementia
Confirmatory Clinical Trial for Verifying the Efficacy and Safety of 'ALZGUARD' as a Digital Dementia Diagnostic Aid-Tool for the Diagnosis of the Major Neurocognitive Disorders
GPS Project Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and Support for the Autonomy of Seniors With Major Neurocognitive Disorders
TDCS as Augmentation Therapy to Cognitive Training in Mild Dementia
Intervention Study of an Individualized Exergame Training for People With Major Neurocognitive Disorder
An Individualized Exergame Training Solution for People With Major Neurocognitive Disorder: a Usability Study
Exergaming in People With Major Neurocognitive Disorder
Automate Music Therapy for the Management of Behavioral Disorders in Nursing Homes